Friday, February 23, 2024
wellness India Expo
Home Tags Syngene

Tag: Syngene

Biocon clocks Rs 4,519 crore revenue in Q3 of FY24, earns...

The company revenue in biosimilars went up by 65%; research services up by 9%; EBITDA stood at Rs 1,492 Crore, up 106%; Net Profit at Rs 660 Crore

Syngene records Rs 3,193 Crore revenue in FY23, up by 23%

Fourth quarter revenue from operations up 31% to Rs. 994 Crore and PAT up 21% to Rs. 179 Crore

Biocon’s Q3 FY23 revenue stands at Rs 3,020 crore, up by...

The company's revenue from operations surged 35% YoY to Rs 2,941 crore for the third quarter under review, compared with Rs 2,174 crore in the last-year period

Syngene International to acquire stake in O2 Renewable Energy II

A special purpose vehicle (SPV) formed by O2 Energy SG Pte Ltd, for generation and supply of renewable power

Syngene International forms a new subsidiary

The company shall be engaged in the business of manufacturing of pharmaceutical, bio-pharmaceutical and biological products of any kind

Syngene International & Amgen extend their collaboration until 2026

Under the extended contract, the dedicated R&D center, ‘Syngene Amgen Research and Development Center’ (SARC), will continue to conduct drug discovery and development projects as part of Amgen’s global R&D program

Syngene makes senior-level appointments to its core team

Alex Del Priore has been appointed as the Senior Vice President, Manufacturing Services. Alan Collis joins as the Vice President, Integrated Drug Discovery services......................

Syngene clocks 12% growth in FY21 revenue at Rs. 2,184 crore

Underlying revenue from operations (excluding export incentives) for the quarter grew 13% compared with the same period last year and by 12% for the full year......................

Industry discusses emerging trends at BioPharma World. IE 2021

Guest of Honour Kris Gopalakrishnan, Chairman, Axilor Ventures & Co-Founder; Infosys & Dr. Dinesh Dua, ED, Nectar Lifesciences & Chairman BioPharma World. IE 2021 felicitated the award winners..........................

Syngene enters into 5-year strategic collaboration with Deerfield Discovery & Development

This five-year collaboration aims to advance therapeutic discovery projects, from target validation through to pharmacological proof of concept and preclinical evaluation.....................